"Despite the ever-increasing numbers of vaccines produced, both states and pharmaceutical companies are continuing to fail to guarantee fair access to lifesaving medicines for all," Amnesty's briefing explains. "Pfizer, one the largest and most profitable vaccine developers... has delivered in excess of 1.8 billion doses to date," the publication continues. "Despite its many pledges—some misleadingly phrased—Pfizer... continues to reserve the bulk of its vaccines for higher-income countries."
96% of people in low-income countries remain unvaccinated.
Pfizer expects to earn 36 billion dollars in vaccine sales this year alone, has distorted reality to benefit its corporate image. Pfizer claimed it is "committed to sharing our scientific tools and insights, development expertise, and manufacturing capacity," yet the company has opposed sharing of intellectual property through the WHO's Covid-19 Technology Access Pool (C-TAP). The company is still refusing to participate in technology sharing initiatives, such as the South African-based [World Health Organization] mRNA technology hub, and has lobbied vigorously against efforts to lift intellectual property restrictions, proposals put forward by India and South Africa to the World Trade Organization Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) to suspend critical intellectual property provisions of the TRIPS Agreement,
"Pfizer is still putting profits before people," Amnesty charges.
Pfizer vaccines language is misleading." The briefing asserts "Pfizer has amalgamated low, lower-middle, and upper-middle countries—over 84% of the global population—into one group and referred to them as 'low and middle-income.' Within this very broad category, the bulk of Pfizer's doses have in fact been going to 'upper-middle' income countries such as Malaysia, Mexico, and Thailand."
Pfizer said it had shipped two billion vaccine doses by the end of September, but only 154 million doses, or less than 8% of its total—had been sent to 42 low and lower-middle-income countries, and that less than 10% of those shots had gone to low-income countries.
Patrick Wilcken, Amnesty's head of business and human rights, said in a statement Thursday that "Pfizer says it is committed to supplying doses to low- and middle-income countries, but the numbers just don't bear this out. The fact is that this company is still putting profits first. As much as these companies might want to massage the facts, the numbers are crystal clear.."
Shame on those countries hoarding vaccines, shame on Big Pharma prioritizing profits over people. Shame on both for blocking attempts to increase vaccine production.
No comments:
Post a Comment